NICE guidance on cost-saving drug not sought by DH

The Department of Health failed to act on expert advice to commission an appraisal of a drug which could lead to savings of £100m for the NHS, it has emerged.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here